MedPath

NAPROXENO/ESOMEPRAZOL SANDOZ 500 MG/20 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

NAPROXENO/ESOMEPRAZOL SANDOZ 500 MG/20 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

Pending
Register Number

89990

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Dec 4, 2024

Dosage Form

COMPRIMIDO DE LIBERACIÓN MODIFICADA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number89990
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (2)

ESOMEPRAZOLE MAGNESIO TRIHIDRATOActive
Quantity: 22,3 mg
Name: ESOMEPRAZOLE MAGNESIO TRIHIDRATO
NAPROXENOActive
Quantity: 500 mg
Name: NAPROXENO

ATC CLASSIFICATION (3)

M01A
M01AE
M01AE52

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.